GRAY MICHAEL
SEC CIK 1271411 · EDGAR
BoughtSold
Most active insiders at UPB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sutherland Everett Rand | CEO, Dir | — | $43.7K |
| 2 | Deykin Aaron | Chief Medical Off | — | $18.7K |
| 3 | GRAY MICHAEL | CFO, COO | — | $17.8K |
| 4 | Houghton Adam | Chief Business Off | — | $14.6K |
| 5 | Ambrose Allison | GC | — | $9,985 |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-17 16:05 | 2026-09-16 | UPB | Upstream Bio, Inc. | GRAY MICHAEL | CFO, COO | S - Sale | $5.49 | -853 | 27.9K | -3% | -$4,683 | |
| 2026-06-17 16:05 | 2026-06-16 | UPB | Upstream Bio, Inc. | GRAY MICHAEL | CFO, COO | S - Sale | $6.10 | -853 | 28.8K | -3% | -$5,203 | |
| 2026-03-17 | 2026-03-16 | UPB | Upstream Bio, Inc. | GRAY MICHAEL | CFO, COO | S - Sale | $9.29 | -852 | 29.6K | -3% | -$7,915 | |
| D | 2026-01-06 | 2026-01-02 | UPB | Upstream Bio, Inc. | GRAY MICHAEL | CFO, COO | A - Grant | $0.00 | +30.5K | 30.5K | New | $0 |
| 2023-02-22 | 2023-02-22 | ELVN | Enliven Therapeutics, Inc. | GRAY MICHAEL | CFO, COO | S - Sale | $4.67 | -9,856 | 27.6K | -26% | -$46.0K | |
| 2023-02-01 | 2023-01-30 | ELVN | Enliven Therapeutics, Inc. | GRAY MICHAEL | CFO, COO | S - Sale | $3.92 | -3,596 | 37.5K | -9% | -$14.1K | |
| D | 2022-02-01 | 2022-01-28 | ELVN | Enliven Therapeutics, Inc. | GRAY MICHAEL | CFO, COO | A - Grant | $0.00 | +39.4K | 42.3K | +1,328% | $0 |
Purchase Sale Sale after option exercise All abbreviations